1. Home
  2. CDXS vs CFFI Comparison

CDXS vs CFFI Comparison

Compare CDXS & CFFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDXS
  • CFFI
  • Stock Information
  • Founded
  • CDXS 2002
  • CFFI 1927
  • Country
  • CDXS United States
  • CFFI United States
  • Employees
  • CDXS N/A
  • CFFI N/A
  • Industry
  • CDXS Major Chemicals
  • CFFI Major Banks
  • Sector
  • CDXS Industrials
  • CFFI Finance
  • Exchange
  • CDXS Nasdaq
  • CFFI Nasdaq
  • Market Cap
  • CDXS 201.3M
  • CFFI 211.9M
  • IPO Year
  • CDXS 2010
  • CFFI 1998
  • Fundamental
  • Price
  • CDXS $3.04
  • CFFI $65.32
  • Analyst Decision
  • CDXS Buy
  • CFFI
  • Analyst Count
  • CDXS 2
  • CFFI 0
  • Target Price
  • CDXS $11.00
  • CFFI N/A
  • AVG Volume (30 Days)
  • CDXS 910.6K
  • CFFI 39.4K
  • Earning Date
  • CDXS 08-07-2025
  • CFFI 07-23-2025
  • Dividend Yield
  • CDXS N/A
  • CFFI 2.76%
  • EPS Growth
  • CDXS N/A
  • CFFI 10.01
  • EPS
  • CDXS N/A
  • CFFI 6.68
  • Revenue
  • CDXS $49,815,000.00
  • CFFI $116,421,000.00
  • Revenue This Year
  • CDXS $12.77
  • CFFI N/A
  • Revenue Next Year
  • CDXS $22.12
  • CFFI N/A
  • P/E Ratio
  • CDXS N/A
  • CFFI $9.99
  • Revenue Growth
  • CDXS N/A
  • CFFI 0.67
  • 52 Week Low
  • CDXS $1.90
  • CFFI $44.04
  • 52 Week High
  • CDXS $6.08
  • CFFI $89.90
  • Technical
  • Relative Strength Index (RSI)
  • CDXS 69.54
  • CFFI 58.98
  • Support Level
  • CDXS $2.55
  • CFFI $64.85
  • Resistance Level
  • CDXS $2.91
  • CFFI $67.75
  • Average True Range (ATR)
  • CDXS 0.20
  • CFFI 2.14
  • MACD
  • CDXS 0.06
  • CFFI 0.75
  • Stochastic Oscillator
  • CDXS 96.17
  • CFFI 86.87

About CDXS Codexis Inc.

Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.

About CFFI C&F Financial Corporation

C&F Financial Corp is an American bank holding company. The company through its subsidiaries offers banking and related financial services to both individuals and businesses. It operates in three business activities: Community Banking, Mortgage Banking, and Consumer Finance. It mainly provides a range of lending activities, which include residential mortgage loans, commercial real estate loans, non-prime automobile lending, land acquisition, and development loans, and consumer loans. The company generates maximum of its revenue from the Community Banking segment.

Share on Social Networks: